MARC

LEADER 00000cam a2200000 i 4500
001 SCIDIR_ocn881724096
003 OCoLC
005 20231120111613.0
006 m o d
007 cr cnu---unuuu
008 140625s1991 mau ob 001 0 eng d
040 |a OPELS  |b eng  |e rda  |e pn  |c OPELS  |d N$T  |d E7B  |d NLGGC  |d YDXCP  |d OCLCQ  |d EBLCP  |d DEBSZ  |d OCLCQ  |d UAB  |d MERUC  |d STF  |d OCLCQ  |d UKAHL  |d OCLCQ  |d OCLCO  |d OCLCA  |d INARC  |d VLY  |d LUN  |d OCLCQ  |d OCLCO  |d OCLCQ 
019 |a 896795481  |a 1162392065  |a 1397425084 
020 |a 9781483165035  |q (electronic bk.) 
020 |a 1483165035  |q (electronic bk.) 
020 |z 040990239X 
020 |z 9780409902396 
035 |a (OCoLC)881724096  |z (OCoLC)896795481  |z (OCoLC)1162392065  |z (OCoLC)1397425084 
043 |a n-us--- 
050 4 |a HF5549.5.D7  |b F38 1991eb 
060 4 |a 2009 B-543 
060 4 |a HF 5549.D7  |b F282d 1991 
072 7 |a BUS  |x 082000  |2 bisacsh 
072 7 |a BUS  |x 041000  |2 bisacsh 
072 7 |a BUS  |x 042000  |2 bisacsh 
072 7 |a BUS  |x 085000  |2 bisacsh 
082 0 4 |a 658.3/822  |2 22 
084 |a 44.39  |2 bcl 
100 1 |a Fay, John,  |d 1934- 
245 1 0 |a Drug testing /  |c John Fay. 
264 1 |a Boston :  |b Butterworth-Heinemann,  |c [1991] 
264 4 |c �1991 
300 |a 1 online resource (xii, 372 pages) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references (pages 345-347) and index. 
588 0 |a Print version record. 
505 0 |a Front Cover; Drug Testing; Copyright Page; Dedication; Table of Contents; Preface; Chapter 1. An Overview; A DRUG-TESTING POLICY; A DRUG-TESTING PROGRAM; FACILITATING DRUG TESTING AND TREATMENT; CHALLENGES TO DRUG-TESTING PROGRAMS; STATE AND LOCAL LEGISLATION; FEDERAL LEGISLATION; CONCLUSION; Appendix 1-A: Sample Certifications Regarding Drug-Free Workplace Requirements; Chapter 2. Defining the Problem; THE DIMENSIONS OF ABUSE; DEFINING THE PROBLEM AND THE EMPLOYER'S NEEDS; USING A DRUG ABUSE SURVEY; TREATMENT MODALITIES; CONCLUSION; Appendix 2-A: A Sample Drug Abuse Survey. 
505 8 |a Chapter 3. Developing a Drug-Testing PolicyOBTAINING INPUT; FINAL POLICY CONTENT; PROBLEMATIC ISSUES; CONCLUSION; Appendix 3-A: Sample Drug-Testing Policies; Appendix 3-B: A Checklist for Drafting a Policy; Chapter 4. Educating Employees; INITIAL PLANNING; BASIC ASSUMPTIONS; RESPONSIBILITY, AUTHORITY, AND SUPPORT; A PLANNING TEAM; PROGRAM DESIGN; PROGRAM IMPLEMENTATION; INSTRUCTORS; PROGRAM EVALUATION; PROGRAM REVISION; ANNOUNCING THE POLICY; Appendix 4-A: A Program Design Checklist; Appendix 4-B: Drug-Testing Questions and Answers for Employees. 
505 8 |a Appendix 4-C: Sample Policy Announcements and Acknowledgment FormsAppendix 4-D: Sample Drug Bulletins; Chapter 5. Training Supervisors; THE NATURE OF LEARNING; THE TRANSFER OF KNOWLEDGE; THE BODY OF KNOWLEDGE; THE PRINCIPLES OF SUPERVISION; THE TRAINING PROCESS; CONCLUSION; Appendix 5-A: Drug-Testing Questions and Answers for Supervisors; Appendix 5-B: Sample Training Materials; Chapter 6. Implementing a Drug-Testing Program; A SUPERVISOR'S INTERVENTION STRATEGY; IMPLEMENTING AN EMPLOYEE ASSISTANCE PROGRAM; SUPPLEMENTS TO DRUG TESTING; SAMPLE PROGRAM MATERIALS. 
505 8 |a Appendix 6-A: Consent for Release of Information and Release of Information MemorandumAppendix 6-B: Drug-Testing Program Procedures Developed for a Municipality; Appendix 6-C: Notice of Legal Drug Use; Appendix 6-D: Guidelines for Supervisors at an Oil and Gas Company; Appendix 6-E: Search Consent; Appendix 6-F: Report of Performance or Behavior Incident; Appendix 6-G: Questionnaire for Contractors; Appendix 6-H: Alcohol- and Drug-Testing Standards for Contractors; Chapter 7. Collecting Specimens for Drug Testing; THE COLLECTION PROCESS; DELAY IN COLLECTING A SPECIMEN; SPLIT SPECIMENS. 
505 8 |a ON-SITE SCREENING OF SPECIMENSAppendix 7-A: Sample Urine Specimen Collection Procedures; Appendix 7-B: Sample Consent Forms; Appendix 7-C: Disclosure of Medication and Ingested Substances; Appendix 7-D: Consent and Waiver; Chapter 8. Understanding the Drug-Testing Program; URINALYSIS; HAIR ANALYSIS; SOME TESTING CONCEPTS; DEFENSES AGAINST A POSITIVE RESULT; LABORATORY CERTIFICATION; CONCLUSION; Chapter 9. Drug Testing in the Federal Workplace; EXECUTIVE ORDER 12564; SECTION 503 OF PUBLIC LAW 100-73; MANDATORY GUIDELINES FOR FEDERAL WORKPLACE DRUG TESTING PROGRAMS; AGENCY PLANS; CUTOFF LEVELS. 
546 |a English. 
650 0 |a Employees  |x Drug testing. 
650 2 |a Personnel Management  |x methods  |0 (DNLM)D010559Q000379 
650 2 |a Substance Abuse Detection  |x methods  |0 (DNLM)D015813Q000379 
650 2 |a Occupational Health Services  |x organization & administration  |0 (DNLM)D009786Q000458 
650 2 |a Substance-Related Disorders  |x diagnosis  |0 (DNLM)D019966Q000175 
650 2 |a Workplace  |x legislation & jurisprudence  |0 (DNLM)D017132Q000331 
651 2 |a United States  |0 (DNLM)D014481 
650 6 |a Personnel  |x Tests de d�epistage des drogues.  |0 (CaQQLa)201-0314693 
650 7 |a BUSINESS & ECONOMICS  |x Industrial Management.  |2 bisacsh 
650 7 |a BUSINESS & ECONOMICS  |x Management.  |2 bisacsh 
650 7 |a BUSINESS & ECONOMICS  |x Management Science.  |2 bisacsh 
650 7 |a BUSINESS & ECONOMICS  |x Organizational Behavior.  |2 bisacsh 
650 7 |a Employees  |x Drug testing.  |2 fast  |0 (OCoLC)fst00909140 
776 0 8 |i Print version:  |a Fay, John, 1934-  |t Drug testing  |z 040990239X  |w (DLC) 90032616  |w (OCoLC)21226254 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/book/9780409902396  |z Texto completo